Načítá se...
Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients
INTRODUCTION: Decreased production of cathelicidin antimicrobial protein-18 (hCAP18) has been proposed to be a key mechanism linking decreased 25-hydroxyvitamin D (25D) levels with adverse outcomes among critically ill patients. However, few studies in humans have directly assessed plasma hCAP18 lev...
Uloženo v:
| Vydáno v: | Crit Care |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4357206/ https://ncbi.nlm.nih.gov/pubmed/25887571 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13054-015-0812-1 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|